BORAGEN INC

Biotech · Private

Novel benzoxaborole molecules designed as antimalarial therapeutics

Grants
$600K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
33
2 granted · 31 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Benzoxaborole-based antimalarial drug discovery$300,500
Federal grantDepartment of Health and Human Services · Phase I · Benzoxaborole-based antimalarial drug discovery$299,639
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1551VISHENARY, LLC——
1552RUBICON BIOTECHNOLOGY LLC——
1553ALISBIO LLC——
1554BORAGEN INC——
1555CELLINFINITY BIO, INC.——
1556Raven Biomaterials LLC——
1557Luxvitae Therapeutics Inc.—$8.5M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 33
  • Chemical Compoundsgranted
  • Solid Forms Of Substituted Benzoxaborole And Compositions Thereofgranted
  • Boron Containing Compounds And Their Usesapplication
  • Flow Reaction Process For Manufacture Of Boron-containing Agrochemicalsapplication
  • Boron Containing Compounds And Their Usesapplication
  • Chemical Compoundsapplication
  • Chemical Compoundsapplication
  • Chemical Compoundsapplication
  • Chemical Compoundsapplication
  • Chemical Compoundsapplication
  • Boron Containing Compounds And Their Usesapplication
  • Chemical Compoundsapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.